Studies have shown an increased risk of several cancers including breast and endometrial cancer in obese women [6, 7] through potential mechanisms, such as promoted mitosis caused by high endogenous estrogen levels, elevated insulin-like growth factor-1 (IGF-1) levels caused by hyperinsulinemia, and chronic inflammation stimulation [8, 9]. This evidence concerns the gene IGF1 and endometrial cancer.